AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 167 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $598,000 | -27.5% | 35,800 | -37.5% | 0.00% | -50.0% |
| Q1 2020 | $825,000 | -49.8% | 57,240 | +16.6% | 0.01% | -45.5% |
| Q4 2019 | $1,643,000 | +248.8% | 49,100 | +118.2% | 0.01% | +175.0% |
| Q3 2019 | $471,000 | -55.8% | 22,500 | -56.1% | 0.00% | -55.6% |
| Q2 2019 | $1,066,000 | – | 51,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|